Abstract | BACKGROUND: METHODS: We measured tetranor PGDM in urine using LC-MS/MS. First morning urine samples were collected from genetically confirmed DMD patients and age-matched healthy controls aged 4 to 15y. RESULTS: The urinary tetranor PGDM concentration was 3.08±0.15 and 6.90±0.35ng/mg creatinine (mean±SE) in 79 control and 191 DMD samples, respectively. The mean concentration was approximately 2.2-times higher in DMD patients than in controls (p<0.05). Remarkably, urinary tetranor PGDM concentrations in DMD patients showed chronological changes: it stayed nearly 1.5 times higher than in controls until 7y but surged at the age of 8y to a significantly higher concentration. CONCLUSION: Urinary tetranor PGDM concentrations were shown to be increased in DMD patients and became higher with advancing age. It was indicated that PGD2-mediated inflammation plays a role in the pathology of DMD.
|
Authors | Taku Nakagawa, Atsuko Takeuchi, Ryohei Kakiuchi, Tomoko Lee, Mariko Yagi, Hiroyuki Awano, Kazumoto Iijima, Yasuhiro Takeshima, Yoshihiro Urade, Masafumi Matsuo |
Journal | Clinica chimica acta; international journal of clinical chemistry
(Clin Chim Acta)
Vol. 423
Pg. 10-4
(Aug 23 2013)
ISSN: 1873-3492 [Electronic] Netherlands |
PMID | 23603101
(Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
|
Copyright | Copyright © 2013 Elsevier B.V. All rights reserved. |
Chemical References |
|
Topics |
- Adolescent
- Age Factors
- Child
- Child, Preschool
- Chromatography, Liquid
- Humans
- Muscular Dystrophy, Duchenne
(pathology, urine)
- Prostaglandin D2
(urine)
- Tandem Mass Spectrometry
|